Literature DB >> 12917104

Parathyroid hormone-related protein ameliorates death receptor-mediated apoptosis in lung cancer cells.

Randolph H Hastings1, Flavio Araiza, Douglas W Burton, Lu Zhang, Maxwell Bedley, Leonard J Deftos.   

Abstract

Parathyroid hormone-related protein (PTHrP) is expressed in more advanced, aggressive tumors and may play an active role in cancer progression. This study investigated the effects of PTHrP on apoptosis after UV irradiation, Fas ligation, or staurosporine treatment in BEN human squamous lung carcinoma cells. Cells at 70% confluency were treated for 24 h with 100 nM PTHrP-(1-34), PTHrP-(38-64), PTHrP-(67-86), PTHrP-(107-139), or PTHrP-(140-173) in media with serum, exposed for 30 min to UV-B radiation (0.9 mJ/cm2), and maintained for another 24 h. Caspase-3, caspase-8, and caspase-9 activities increased fivefold. Pretreatment with PTHrP-(1-34) and PTHrP-(140-173) ameliorated apoptosis after UV irradiation, as indicated by reduced caspase activities, increased cell protein, decreased nuclear condensation, and increased clonal survival. Other peptides had no effect on measures of apoptosis. PTHrP-(140-173) also reduced caspase activities after Fas ligation by activating antibody, but neither peptide had effects on caspase-3 or caspase-9 activity after 1 microM staurosporine. These data indicate that PTHrP-(1-34) and PTHrP-(140-173) protect against death receptor-induced apoptosis in BEN lung cancer cells but are ineffective against mitochondrial pathways. PTHrP contributes to lung cancer cell survival in culture and could promote cancer progression in vivo. The mechanism for the protective effect against apoptosis remains to be determined.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12917104     DOI: 10.1152/ajpcell.00269.2003

Source DB:  PubMed          Journal:  Am J Physiol Cell Physiol        ISSN: 0363-6143            Impact factor:   4.249


  6 in total

1.  Lack of epithelial PPARγ causes cystic adenomatoid malformations in mouse fetal lung.

Authors:  Jung-Hwan Kim; Satoshi Yamaori; Tomotaka Tanabe; Mitsuhiro Takagi; Tsutomu Matsubara; Minoru Okamoto; Shioko Kimura; Frank J Gonzalez
Journal:  Biochem Biophys Res Commun       Date:  2017-07-21       Impact factor: 3.575

2.  Osteoblast-derived PTHrP is a potent endogenous bone anabolic agent that modifies the therapeutic efficacy of administered PTH 1-34.

Authors:  Dengshun Miao; Bin He; Yebin Jiang; Tatsuya Kobayashi; Maria A Sorocéanu; Jenny Zhao; Hanyi Su; Xinkang Tong; Norio Amizuka; Ajay Gupta; Harry K Genant; Henry M Kronenberg; David Goltzman; Andrew C Karaplis
Journal:  J Clin Invest       Date:  2005-09       Impact factor: 14.808

3.  Cell cycle actions of parathyroid hormone-related protein in non-small cell lung carcinoma.

Authors:  Randolph H Hastings; Philippe R Montgrain; Rick Quintana; Yvette Rascon; Leonard J Deftos; Erin Healy
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2009-07-24       Impact factor: 5.464

4.  Tumor expressed PTHrP facilitates prostate cancer-induced osteoblastic lesions.

Authors:  Jinhui Liao; Xin Li; Amy J Koh; Janice E Berry; Nanda Thudi; Thomas J Rosol; Kenneth J Pienta; Laurie K McCauley
Journal:  Int J Cancer       Date:  2008-11-15       Impact factor: 7.396

Review 5.  Role of key players in paradigm shifts of prostate cancer bone metastasis.

Authors:  Ayesha Sohail; Lubna Sherin; Saad I Butt; Sana Javed; Zhiwu Li; Sohail Iqbal; O Anwar Be'g
Journal:  Cancer Manag Res       Date:  2018-06-21       Impact factor: 3.989

6.  Coherent expression chromosome cluster analysis reveals differential regulatory functions of amino-terminal and distal parathyroid hormone-related protein domains in prostate carcinoma.

Authors:  I Tsigelny; D W Burton; Y Sharikov; R H Hastings; L J Deftos
Journal:  J Biomed Biotechnol       Date:  2005
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.